TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 299 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,676,070 | -2.6% | 302,267 | -1.0% | 0.06% | +5.5% |
| Q2 2023 | $4,798,714 | +3.1% | 305,456 | +8.1% | 0.06% | +1.9% |
| Q1 2023 | $4,655,880 | +2.9% | 282,517 | -2.6% | 0.05% | -3.6% |
| Q4 2022 | $4,526,543 | +18.0% | 290,163 | -1.9% | 0.06% | +12.0% |
| Q3 2022 | $3,835,000 | -7.3% | 295,706 | +0.3% | 0.05% | +4.2% |
| Q2 2022 | $4,138,000 | -0.8% | 294,799 | +1.2% | 0.05% | +20.0% |
| Q1 2022 | $4,172,000 | -4.1% | 291,402 | -8.7% | 0.04% | +11.1% |
| Q4 2021 | $4,351,000 | -17.5% | 319,305 | -0.8% | 0.04% | -20.0% |
| Q3 2021 | $5,274,000 | -3.3% | 322,022 | -0.7% | 0.04% | 0.0% |
| Q2 2021 | $5,456,000 | – | 324,229 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
| GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
| Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
| BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
| Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
| Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
| Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
| DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
| TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |